PASER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Paser, and when can generic versions of Paser launch?
Paser is a drug marketed by Eurocept Pharms and is included in one NDA.
The generic ingredient in PASER is aminosalicylic acid. There are fifteen drug master file entries for this compound. Additional details are available on the aminosalicylic acid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PASER?
- What are the global sales for PASER?
- What is Average Wholesale Price for PASER?
Summary for PASER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 151 |
| Patent Applications: | 2,933 |
| DailyMed Link: | PASER at DailyMed |
US Patents and Regulatory Information for PASER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eurocept Pharms | PASER | aminosalicylic acid | GRANULE, DELAYED RELEASE;ORAL | 074346-001 | Jun 30, 1994 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
